The effects of monoclonal antibodies against iC3b receptors in mice with experimentally induced disseminated candidiasis

Kwanghoon Lee, M. S. Yoon, W. H. Chun

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

CR3 (iC3b receptor); composed of CD11b/CD18, is a β2 integrin. A protein that shares antigenic and structural homology with the α-chain of CD11b/CD18 has been isolated from the surface of Candida albicans. This molecule is thought to be essential in the pathogenesis of disseminated candidiasis. To evaluate the effects of anti-iC3b receptor antibodies on adhesion between human dermal microvascular endothelial cells (HDMEC) and C. albicans, and in treatment of candidal infection, a binding assay of C. albicans to cultured HDMEC was performed in vitro. An anti-iC3b receptor- specific monoclonal antibody was administered to mice infected with C. albicans. The mice were monitored for mortality and renal involvement by culture and histopathological findings. Flow cytometric analysis demonstrated surface expression of iC3b receptor on C. albicans. The adherence of C. albicans to HDMEC was significantly decreased by treatment with anti-iC3b receptor antibodies. Anti-iC3b receptor antibodies significantly increased the survival time and rate while lowering the renal fungal burden. The iC3b receptors are involved in the adherence of C. albicans to vascular endothelial cells and are likely to be involved in the pathogenesis of disseminated candidiasis. The increased survival in mice infected with C. albicans after treatment with anti-iC3b receptor antibodies indicates that this modality maybe beneficial for future development of a new therapy for candidiasis.

Original languageEnglish
Pages (from-to)104-110
Number of pages7
JournalImmunology
Volume92
Issue number1
DOIs
Publication statusPublished - 1997 Jan 1

Fingerprint

Complement C3b
Candidiasis
Candida albicans
Monoclonal Antibodies
Endothelial Cells
Antibodies
Skin
Macrophage-1 Antigen
Kidney
Integrins
Survival Rate
Survival
Mortality

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

@article{62a3d2731d6e4b9eba0b4a5e79275d91,
title = "The effects of monoclonal antibodies against iC3b receptors in mice with experimentally induced disseminated candidiasis",
abstract = "CR3 (iC3b receptor); composed of CD11b/CD18, is a β2 integrin. A protein that shares antigenic and structural homology with the α-chain of CD11b/CD18 has been isolated from the surface of Candida albicans. This molecule is thought to be essential in the pathogenesis of disseminated candidiasis. To evaluate the effects of anti-iC3b receptor antibodies on adhesion between human dermal microvascular endothelial cells (HDMEC) and C. albicans, and in treatment of candidal infection, a binding assay of C. albicans to cultured HDMEC was performed in vitro. An anti-iC3b receptor- specific monoclonal antibody was administered to mice infected with C. albicans. The mice were monitored for mortality and renal involvement by culture and histopathological findings. Flow cytometric analysis demonstrated surface expression of iC3b receptor on C. albicans. The adherence of C. albicans to HDMEC was significantly decreased by treatment with anti-iC3b receptor antibodies. Anti-iC3b receptor antibodies significantly increased the survival time and rate while lowering the renal fungal burden. The iC3b receptors are involved in the adherence of C. albicans to vascular endothelial cells and are likely to be involved in the pathogenesis of disseminated candidiasis. The increased survival in mice infected with C. albicans after treatment with anti-iC3b receptor antibodies indicates that this modality maybe beneficial for future development of a new therapy for candidiasis.",
author = "Kwanghoon Lee and Yoon, {M. S.} and Chun, {W. H.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1046/j.1365-2567.1997.t01-1-00321.x",
language = "English",
volume = "92",
pages = "104--110",
journal = "Immunology",
issn = "0019-2805",
publisher = "Wiley-Blackwell",
number = "1",

}

The effects of monoclonal antibodies against iC3b receptors in mice with experimentally induced disseminated candidiasis. / Lee, Kwanghoon; Yoon, M. S.; Chun, W. H.

In: Immunology, Vol. 92, No. 1, 01.01.1997, p. 104-110.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The effects of monoclonal antibodies against iC3b receptors in mice with experimentally induced disseminated candidiasis

AU - Lee, Kwanghoon

AU - Yoon, M. S.

AU - Chun, W. H.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - CR3 (iC3b receptor); composed of CD11b/CD18, is a β2 integrin. A protein that shares antigenic and structural homology with the α-chain of CD11b/CD18 has been isolated from the surface of Candida albicans. This molecule is thought to be essential in the pathogenesis of disseminated candidiasis. To evaluate the effects of anti-iC3b receptor antibodies on adhesion between human dermal microvascular endothelial cells (HDMEC) and C. albicans, and in treatment of candidal infection, a binding assay of C. albicans to cultured HDMEC was performed in vitro. An anti-iC3b receptor- specific monoclonal antibody was administered to mice infected with C. albicans. The mice were monitored for mortality and renal involvement by culture and histopathological findings. Flow cytometric analysis demonstrated surface expression of iC3b receptor on C. albicans. The adherence of C. albicans to HDMEC was significantly decreased by treatment with anti-iC3b receptor antibodies. Anti-iC3b receptor antibodies significantly increased the survival time and rate while lowering the renal fungal burden. The iC3b receptors are involved in the adherence of C. albicans to vascular endothelial cells and are likely to be involved in the pathogenesis of disseminated candidiasis. The increased survival in mice infected with C. albicans after treatment with anti-iC3b receptor antibodies indicates that this modality maybe beneficial for future development of a new therapy for candidiasis.

AB - CR3 (iC3b receptor); composed of CD11b/CD18, is a β2 integrin. A protein that shares antigenic and structural homology with the α-chain of CD11b/CD18 has been isolated from the surface of Candida albicans. This molecule is thought to be essential in the pathogenesis of disseminated candidiasis. To evaluate the effects of anti-iC3b receptor antibodies on adhesion between human dermal microvascular endothelial cells (HDMEC) and C. albicans, and in treatment of candidal infection, a binding assay of C. albicans to cultured HDMEC was performed in vitro. An anti-iC3b receptor- specific monoclonal antibody was administered to mice infected with C. albicans. The mice were monitored for mortality and renal involvement by culture and histopathological findings. Flow cytometric analysis demonstrated surface expression of iC3b receptor on C. albicans. The adherence of C. albicans to HDMEC was significantly decreased by treatment with anti-iC3b receptor antibodies. Anti-iC3b receptor antibodies significantly increased the survival time and rate while lowering the renal fungal burden. The iC3b receptors are involved in the adherence of C. albicans to vascular endothelial cells and are likely to be involved in the pathogenesis of disseminated candidiasis. The increased survival in mice infected with C. albicans after treatment with anti-iC3b receptor antibodies indicates that this modality maybe beneficial for future development of a new therapy for candidiasis.

UR - http://www.scopus.com/inward/record.url?scp=0030848489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030848489&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2567.1997.t01-1-00321.x

DO - 10.1046/j.1365-2567.1997.t01-1-00321.x

M3 - Article

VL - 92

SP - 104

EP - 110

JO - Immunology

JF - Immunology

SN - 0019-2805

IS - 1

ER -